Who owns Alexion Pharmaceuticals?

Key details on Alexion Pharmaceuticals (Ticker: ALXN)

Who owns Alexion Pharmaceuticals?

Is ALXN a good stock to own? Find out who bought Alexion Pharmaceuticals, who sold Alexion Pharmaceuticals (ALXN) stock, and who holds a large position in Alexion Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 100.55M $100.55M March 31, 2015
Capital Research Global Investors^ 24.76M $4.29B March 31, 2015
T. Rowe Price Associates 22.08M $3.83B March 31, 2015
FMR 14.94M $2.70B June 30, 2015
Vanguard 13.05M $2.36B June 30, 2015
STATE STREET CORPORATION 8.47M $1.47B March 31, 2015
Sands Capital Management 6.52M $1.18B June 30, 2015
Jennison Associates 5.95M $1.08B June 30, 2015
BlackRock Institutional Trust Company, N.A. 5.65M $1.02B June 30, 2015
VIKING GLOBAL INVESTORS 5.54M $511.47M June 30, 2013
JPMORGAN CHASE & CO 5.31M $959.92M June 30, 2015
Ameriprise Financial 4.98M $899.82M June 30, 2015
BlackRock Fund Advisors 4.73M $855.50M June 30, 2015
Wells Fargo & Company 4.28M $742.47M March 31, 2015
Inves 4.15M $631.87M March 31, 2014

Who sold Alexion Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management Dec. 31, 2011 4.73M $338.08M
American Century Companies June 30, 2011 3.90M $183.41M